-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $843

Benzinga·12/29/2025 10:42:47
语音播报
BTIG analyst Kambiz Yazdi maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $507 to $843.